Vector analysis of astigmatic correction after single-step transepithelial photorefractive keratectomy and femtosecond-assisted laser


Journal

Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376

Informations de publication

Date de publication:
10 2022
Historique:
entrez: 3 10 2022
pubmed: 4 10 2022
medline: 5 10 2022
Statut: ppublish

Résumé

This study aimed to evaluate the outcomes of astigmatic correction by single-step transepithelial photorefractive keratectomy (TransPRK) and femtosecond-assisted laser in-situ keratomileusis (Femto-LASIK) surgeries. A total of 218 subjects received TransPRK or Femto-LASIK surgery for the treatment of myopia and astigmatism (-2.25 to -0.25 D). Refraction errors and uncorrected (UDVA) and corrected distance visual acuity (CDVA) were examined before and at 3 months after surgery. Astigmatism changes were assessed by vector analysis. Preoperative parameters of the TransPRK group were similar to the Femto-LASIK group. UDVA and CDVA at 3 months were similar between both groups. Manifest refraction (MR) spherical equivalent in the TransPRK group (0 ± 0.20 D) was slightly lower compared with the Femto-LASIK group at 3 months (0.11 ± 0.25 D, P = 0.001). MR cylinder was -0.06 ± 0.19 D in the TransPRK group and -0.02 ± 0.15 D in the Femto-LASIK group at 3 months (P = 0.135). The index of success (IS) was 0.15 ± 0.36 in the TransPRK group and 0.06 ± 0.17 in the Femto-LASIK group (P = 0.125). The correction index (CI) was 1.03 ± 0.19 in the TransPRK group and 1.01 ± 0.11 in the Femto-LASIK group (P = 0.815). For low to moderate myopic astigmatism, TransPRK provided a comparable astigmatic treatment effect as Femto-LASIK. Myopic astigmatism was both slightly overcorrected after TransPRK and Femto-LASIK surgeries.

Identifiants

pubmed: 36190031
pii: IndianJOphthalmol_2022_70_10_3483_357428
doi: 10.4103/ijo.IJO_649_22
pmc: PMC9789874
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3483-3489

Déclaration de conflit d'intérêts

None

Références

J Cataract Refract Surg. 2013 Jan;39(1):74-80
pubmed: 23158679
J Cataract Refract Surg. 2001 Jan;27(1):31-49
pubmed: 11165856
J Refract Surg. 2013 Dec;29(12):832-7
pubmed: 24088061
Cornea. 2018 Jan;37(1):45-52
pubmed: 29053556
Am J Ophthalmol. 2015 May;159(5):835-45.e3
pubmed: 25681001
J Cataract Refract Surg. 2012 Aug;38(8):1414-23
pubmed: 22814048
J Cataract Refract Surg. 2016 Nov;42(11):1570-1578
pubmed: 27956283
Ophthalmology. 2002 Jan;109(1):175-87
pubmed: 11772601
Acta Inform Med. 2020 Sep;28(3):180-184
pubmed: 33417662
Cornea. 2019 Jan;38(1):98-104
pubmed: 30308583
J Cataract Refract Surg. 2017 Feb;43(2):174-182
pubmed: 28366363
BMC Ophthalmol. 2018 May 9;18(1):115
pubmed: 29743044
Int Ophthalmol. 2019 Apr;39(4):753-763
pubmed: 29532217
Eye Contact Lens. 2019 Mar;45(2):132-136
pubmed: 30067519
Br J Ophthalmol. 2017 Aug;101(8):1106-1112
pubmed: 27941045
BMC Ophthalmol. 2020 Jun 19;20(1):243
pubmed: 32560634
Br J Ophthalmol. 2016 Apr;100(4):553-9
pubmed: 26206791
Ophthalmology. 2013 Mar;120(3):e5-e20
pubmed: 23174396
J Cataract Refract Surg. 2011 Mar;37(3):454-60
pubmed: 21333869
J Cataract Refract Surg. 2011 Jan;37(1):1-3
pubmed: 21183094
J Refract Surg. 2018 Jul 1;34(7):466-474
pubmed: 30001450
Am J Ophthalmol. 2015 Sep;160(3):493-505
pubmed: 26025425
Clin Ophthalmol. 2015 Jul 13;9:1291-8
pubmed: 26203219
Br J Ophthalmol. 2013 Jul;97(7):905-11
pubmed: 23603760
J Cataract Refract Surg. 2011 Oct;37(10):1852-7
pubmed: 21840678
J Cataract Refract Surg. 1997 Dec;23(10):1503-14
pubmed: 9456408
J Cataract Refract Surg. 2013 Mar;39(3):366-77
pubmed: 23506918

Auteurs

Lixia Sun (L)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong Province, China.

Vishal Jhanji (V)

UPMC Eye Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.

Senmao Li (S)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong Province, China.

Jinyu Li (J)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong Province, China.

Ruifeng Ji (R)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong Province, China.

Hongqiang Zeng (H)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong Province, China.

Tsz Kin Ng (TK)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong Province, China.

Mingzhi Zhang (M)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong Province, China.

Riping Zhang (R)

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong Province, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH